11.25
Meiragtx Holdings Plc stock is traded at $11.25, with a volume of 630.50K.
It is down -0.35% in the last 24 hours and up +52.23% over the past month.
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
See More
Previous Close:
$11.29
Open:
$11.4
24h Volume:
630.50K
Relative Volume:
1.30
Market Cap:
$916.27M
Revenue:
$81.39M
Net Income/Loss:
$-114.20M
P/E Ratio:
-7.8931
EPS:
-1.4253
Net Cash Flow:
$-50.60M
1W Performance:
+19.81%
1M Performance:
+52.23%
6M Performance:
+38.21%
1Y Performance:
+106.42%
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Name
Meiragtx Holdings Plc
Sector
Industry
Phone
646-860-7985
Address
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MGTX
Meiragtx Holdings Plc
|
11.25 | 919.53M | 81.39M | -114.20M | -50.60M | -1.4253 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Initiated | H.C. Wainwright | Buy |
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jul-31-24 | Resumed | Chardan Capital Markets | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Sep-15-20 | Resumed | BofA Securities | Buy |
| Sep-03-19 | Initiated | Piper Jaffray | Overweight |
| Feb-27-19 | Reiterated | Chardan Capital Markets | Buy |
| Jul-03-18 | Initiated | Barclays | Overweight |
| Jul-03-18 | Initiated | BofA/Merrill | Buy |
View All
Meiragtx Holdings Plc Stock (MGTX) Latest News
MeiraGTx rises on upcoming phase 1 readout for gene therapy - MSN
MeiraGTx: Turning Dry Mouth Into Liquid Gold (NASDAQ:MGTX) - Seeking Alpha
MeiraGTx Holdings (MGTX) Shares Surge 17% on Upcoming Gene Thera - GuruFocus
MeiraGTx to present 3-year data from xerostomia gene therapy trial - Investing.com India
MeiraGTx sets trial readout for gene therapy (MGTX:NASDAQ) - Seeking Alpha
MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026 - Bitget
Quarterly Recap: What is the earnings history of MeiraGTx Holdings plc2026 Setups & Growth Focused Investment Plans - baoquankhu1.vn
Earnings Recap: How liquid is MeiraGTx Holdings plc stockTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Naylor, MeiraGTx chief dev. officer, sells $258,906 in shares By Investing.com - Investing.com Canada
Insider Sell Alert: Stuart Naylor Sells Shares of MeiraGTx Holdings PLC - GuruFocus
MeiraGTx (MGTX) CDO Stuart Naylor sells 27,661 shares via 10b5-1 plan - Stock Titan
Naylor, MeiraGTx chief dev. officer, sells $258,906 in shares - Investing.com
[144] MeiraGTx Holdings plc SEC Filing - Stock Titan
MeiraGTx (NASDAQ:MGTX) Hits New 52-Week HighTime to Buy? - MarketBeat
MeiraGTx (NASDAQ:MGTX) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
(MGTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
MGTX Technical Analysis & Stock Price Forecast - Intellectia AI
What Does The Future Hold For MeiraGTx Holdings plc (NASDAQ:MGTX)? These Analysts Have Been Cutting Their Estimates - Sahm
MeiraGTx Holdings plc Ordinary Shares MGTX ) Stock Price Today & Analysis - Gotrade
MeiraGTx Holdings plc Ordinary Shares (MGTX) Stock Price Today & Analysis - heygotrade.com
MGTX: Evercore ISI Group Lowers Price Target for MeiraGTx Hldgs | MGTX Stock News - GuruFocus
MeiraGTx Holdings PLC $MGTX Shares Bought by Hennion & Walsh Asset Management Inc. - MarketBeat
MGTX: Evercore ISI Group Lowers Price Target for MeiraGTx Hldgs - GuruFocus
Strength Displayed by MeiraGTx (MGTX): Will Its 6.2% Surge Lead to Further Gains? - Bitget
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength? - Yahoo Finance
Performance Recap: Can MeiraGTx Holdings plc deliver consistent EPS growth2026 Rallies & Community Trade Idea Sharing Platform - baoquankhu1.vn
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st
MeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
MeiraGTx 2025 Annual Report Highlights: Gene Therapy Pipeline, Strategic Partnerships, and Proprietary Riboswitch Platform - Minichart
MeiraGTx 2025 10-K: Revenue $81.4M, EPS (1.42) - TradingView
MeiraGTx (NASDAQ: MGTX) expands gene therapy partnerships and manufacturing - Stock Titan
MeiraGTx Holdings plc (MGTX) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
Live MeiraGTx Holdings plc (MGTX) Technical Analysis - tradersunion.com
Bank of America Forecasts Strong Price Appreciation for MeiraGTx (NASDAQ:MGTX) Stock - Defense World
MeiraGTx Holdings plc (MGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
MGTX SEC FilingsMeiragtx Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan
MeiraGTx Holdings PLC (MGTX) Q4 earnings and revenues surpass estimates - MSN
Piper Sandler cuts MeiraGTx stock price target on valuation By Investing.com - Investing.com Australia
Piper Sandler Lowers MeiraGTx (NASDAQ:MGTX) Price Target to $26.00 - MarketBeat
Piper Sandler cuts MeiraGTx stock price target on valuation - Investing.com UK
MeiraGTx (NASDAQ:MGTX) Issues Earnings Results - MarketBeat
MeiraGTx (NASDAQ:MGTX) Price Target Raised to $16.00 at Bank of America - MarketBeat
MeiraGTx (NASDAQ:MGTX) Earns Buy Rating from Chardan Capital - MarketBeat
MeiraGTx Receives FDA Breakthrough Therapy Designation for AAV2-hAQP1 and Reports Strong 2025 Financial Results - Minichart
BofA raises MeiraGTx stock price target to $16 on FDA designation - uk.investing.com
BofA raises MeiraGTx stock price target to $16 on FDA designation By Investing.com - Investing.com India
MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances - TipRanks
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
MeiraGTx shares see Raymond James price target cut on launch timing By Investing.com - Investing.com South Africa
Meiragtx Holdings Plc Stock (MGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):